Why the study?
Are ACE2 variants associated with the penetrance and severity of hypertension and COVID-19 outcomes in obese smoking males?
Are ACE2 variants associated with the penetrance and severity of hypertension and COVID-19 outcomes in obese smoking males?
ACE2 variants may serve as a genetic risk factor for earlier, more severe hypertension and worse COVID-19 outcomes specifically in obese smoking males.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ACE2 genotyping in obese smoking males; prospective validation required before any clinical application.
This is the first report that ACE2 variants are associated with earlier penetrance and more severe HT and with more severe outcomes of COVID-19 in obese smoking males.
No takes yet. Share an insight, caveat, or question.
Hamet et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: